ACCESS Newswire Inc. (ACCS) delivered earnings and revenue surprises of +33.33% and +1.29%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the ...
I've been subjecting AI models to a set of real-world programming tests for over two years. This time, we look solely at the ...
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced new data from the Phase 3 DUPLEX Study demonstrating that patients with focal segmental glomerulosclerosis (FSGS) treated with FILSPARI® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback